• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    International Star Inc. Appoints Todd Masse as New CEO

    4/10/24 8:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $ACB alert in real time by email

    DOVER, DE / ACCESSWIRE / April 10, 2024 / International Star, Inc. (OTC:ILST) (the "Company" or "ILST") is pleased to announce the appointment of Todd Masse as its new Chief Executive Officer effective April 3, 2024. Mr. Masse has over 25 years of extensive experience managing and operating businesses across various industries, including startups, consumer-packaged goods, technology, and real estate.

    Since 2015, Mr. Masse has been a key figure in the cannabis industry, serving as both an entrepreneur and operator. His visionary leadership and innovative approach have driven growth and success in this rapidly evolving sector.

    Mr. Masse's achievements include serving as President of Cannabis Compliance Inc., leading the company to become a frontrunner in compliance solutions. Under his leadership, the company was acquired by Deloitte.

    Additionally, as Chief Commercial Officer (CCO) of Thrive Cannabis, Mr. Masse successfully introduced the Greybeard cannabis brand, pioneering Canada's first BHO and Live Resin products. His efforts significantly contributed to the company's acquisition by Aurora Cannabis Inc. (NASDAQ:ACB)(TSX:ACB) for thirty-eight million dollars ($38,000,000).

    "We are thrilled to welcome Todd Masse as our new CEO," said former interim CEO Nochum Greenberg. "His track record of success and deep industry knowledge make him the ideal leader to drive our company forward. We are confident that International Star will continue to grow and thrive under his guidance."

    Mr. Masse stated: "I am honored and excited to join ILST at such a pivotal moment in the cannabis industry. The potential for growth and impact in this industry is immense, and I am eager to work alongside our talented team to drive forward our mission of delivering high-quality products and experiences to our customers while advancing the industry. I'm looking forward to connecting with shareholders and outlining my vision and plans in an upcoming letter to investors.

    About International Star Inc:
    International Star Inc. (OTC:ILST) operates through its wholly-owned subsidiary, Budding Equity Inc. ("BEi") and its 20% ownership stake in B Studios LLC. BEi owns and licenses intellectual property through contracts with movie studios and celebrities and structures licensing deals with third parties for cannabis-related products. The company also maintains joint ventures with affiliates of Ice Cube and Kevin Smith to license and brand cannabis and cannabis-related products. B Studios focuses on producing cannabis-themed films and capitalizing on product placement and licensing. A core focus of ILST remains acquiring and developing innovative businesses with high growth potential in the cannabis space and beyond. For more information, you can visit our website at www.ilstinc.com.

    For media inquiries, please contact: mailto:[email protected]

    Contact Information:
    International Star, Inc.
    8 The Green
    Suite 16020
    Dover, DE 19901
    Website: www.ilstinc.com

    Forward-Looking Statements:
    This press release contains "forward-looking statements." Words such as "may," "should," "will," "could," "would," "predicts," "potential," "continue," "expects," "anticipates," "confident," "future," "intends," "plans," "believes," "estimates," and similar expressions, as well as statements in the future tense, often signify forward-looking statements. These forward-looking statements are, by their nature, subject to significant risks and uncertainties.

    Forward-looking statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or results will be achieved. Forward-looking statements are based on information that the Company has when those statements are made or management's good faith belief as of that time concerning future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements, including factors beyond the Company's control. As a result of these and other risks, uncertainties, and assumptions, forward-looking events and circumstances discussed herein might not occur in the way the Company expects or at all. Accordingly, readers should not place reliance on any forward-looking information or statements. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events, or otherwise. All forward-looking statements herein are qualified by reference to the cautionary statements outlined in this section.

    SOURCE: International Star, Inc.



    View the original press release on accesswire.com

    Get the next $ACB alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACB

    DatePrice TargetRatingAnalyst
    12/11/2024Buy
    TD Cowen
    2/9/2024Hold → Buy
    Canaccord Genuity
    9/21/2022Sell → Hold
    Canaccord Genuity
    6/24/2022Neutral → Overweight
    Cantor Fitzgerald
    6/6/2022Sell → Hold
    Stifel
    11/10/2021$9.60 → $10.75Neutral
    Cantor Fitzgerald
    10/28/2021$9.50 → $9.60Neutral
    Cantor Fitzgerald
    10/5/2021$8.30 → $9.50Neutral
    Cantor Fitzgerald
    More analyst ratings

    $ACB
    SEC Filings

    View All

    SEC Form 6-K filed by Aurora Cannabis Inc.

    6-K - AURORA CANNABIS INC (0001683541) (Filer)

    8/8/25 7:46:30 PM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Aurora Cannabis Inc.

    6-K - AURORA CANNABIS INC (0001683541) (Filer)

    8/6/25 7:21:42 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Aurora Cannabis Inc.

    6-K - AURORA CANNABIS INC (0001683541) (Filer)

    8/6/25 7:02:41 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aurora Ignites Global Expansion with Whistler Cannabis Co. Brand Debut in Australia

    Canada's Largest Medical Cannabis Company to Launch Two High-Potency Cultivars, Expanding Patient Choice in Australia EDMONTON, ALBERTA, Aug. 12, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announces the launch of Whistler Cannabis Co. in Australia. As one of Canada's original cannabis brands, with a proud history of growing premium, indoor craft cannabis, this unique brand offers Australian patients a true Canadian cannabis experience. "Whistler is a tried-and-true brand in the Canadian market,"

    8/12/25 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting

    NASDAQ | TSX: ACB EDMONTON, AB, Aug. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held Friday August 8, 2025 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 17,736,521 common shares, representing 31.53% of Aurora's issued and outstanding common shares as of the record date.

    8/8/25 5:00:00 PM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Aurora to Participate in Canaccord Genuity 45th Annual Growth Conference

    Canada's Largest Medical Cannabis Company to Discuss Strategy, Industry Trends, and Long-Term Growth Outlook EDMONTON, ALBERTA, Aug. 7, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, will participate in Canaccord Genuity 45th Annual Growth Conference in Boston, MA. Simona King, Chief Financial Officer at Aurora, will take part in a fireside chat on August 13th at 1:30pm EST and conduct one-on-one meetings with investors throughout the day. The discussion will cover Aurora's strategic direction, recen

    8/7/25 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen initiated coverage on Aurora Cannabis

    TD Cowen initiated coverage of Aurora Cannabis with a rating of Buy

    12/11/24 10:35:16 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Aurora Cannabis upgraded by Canaccord Genuity

    Canaccord Genuity upgraded Aurora Cannabis from Hold to Buy

    2/9/24 6:09:16 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Aurora Cannabis upgraded by Canaccord Genuity

    Canaccord Genuity upgraded Aurora Cannabis from Sell to Hold

    9/21/22 9:02:55 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    Leadership Updates

    Live Leadership Updates

    View All

    Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting

    NASDAQ | TSX: ACB EDMONTON, AB, Aug. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held Friday August 8, 2025 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 17,736,521 common shares, representing 31.53% of Aurora's issued and outstanding common shares as of the record date.

    8/8/25 5:00:00 PM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Rubicon Organics Announces Appointment of Glen Ibbott as Interim CFO

    VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV:ROMJ) (OTCQX:ROMJF) ("Rubicon Organics" or the "Company"), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, today announced the appointment of Glen Ibbott, a cannabis industry veteran and former Chief Financial Officer of Aurora Cannabis Inc. (TSX:ACB, NASDAQ:ACB) as its Interim Chief Financial Officer. Janis Risbin, current CFO, will be stepping away from her full-time role effective today. She will remain in an advisory role over the next few months to ensure a smooth transition of responsibilities to Mr. Ibbott. "Glen's leadership at Aurora C

    5/15/25 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors

    NASDAQ | TSX: ACB Outgoing Chairman Ron Funk appointed Lead Independent Director, as part of Board leadership transition EDMONTON, AB, Sept. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced the appointments of CEO Miguel Martin to the additional role of Executive Chairman and outgoing Chairman Ron Funk as Lead Independent Director. Both appointments follow unanimous votes by Aurora's Board and are effective immediately. Mr. Martin has served as Chief Executiv

    9/20/24 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    Financials

    Live finance-specific insights

    View All

    Aurora to Participate in Canaccord Genuity 45th Annual Growth Conference

    Canada's Largest Medical Cannabis Company to Discuss Strategy, Industry Trends, and Long-Term Growth Outlook EDMONTON, ALBERTA, Aug. 7, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, will participate in Canaccord Genuity 45th Annual Growth Conference in Boston, MA. Simona King, Chief Financial Officer at Aurora, will take part in a fireside chat on August 13th at 1:30pm EST and conduct one-on-one meetings with investors throughout the day. The discussion will cover Aurora's strategic direction, recen

    8/7/25 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Aurora Cannabis Announces Fiscal 2026 First Quarter Results

    NASDAQ | TSX: ACB Expands YoY Global Medical Cannabis Net Revenue1 by 37% to $64.8 million, while increasing International Medical Cannabis Net Revenue1 by 85% to $37.1 millionDelivers Adjusted EBITDA1 growth in excess of 200%, reaching $10.8 million Generates Positive Free Cash Flow1 of $9.2 million, representing significant YoY growth of 42% Maintains Strong Balance Sheet with ~$186.0 million of Cash and Debt-Free Cannabis Business2EDMONTON, AB, Aug. 6, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the first quarter 2026 period end

    8/6/25 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Aurora Cannabis to Host First Quarter 2026 Investor Conference Call

          NASDAQ | TSX: ACB EDMONTON, AB, July 23, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its first quarter 2026 on Wednesday, August 6, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the first quarter 2026 before the opening of markets that same day. Conference Call Details DATE: Wednesday, August 6, 2025 TIME: 8:00 a.m. Easte

    7/23/25 5:35:00 PM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Aurora Cannabis Inc. (Amendment)

    SC 13G/A - AURORA CANNABIS INC (0001683541) (Subject)

    2/14/23 11:28:04 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G filed by Aurora Cannabis Inc.

    SC 13G - AURORA CANNABIS INC (0001683541) (Subject)

    6/1/22 10:14:29 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by Aurora Cannabis Inc. (Amendment)

    SC 13G/A - AURORA CANNABIS INC (0001683541) (Subject)

    2/14/22 3:54:29 PM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care